Financial giants have made a conspicuous bearish move on Kenvue. Our analysis of options history for Kenvue KVUE revealed 11 unusual trades.
Delving into the details, we found 36% of traders were bullish, while 63% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $197,837, and 6 were calls, valued at $874,156.
Predicted Price Range
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $19.0 to $23.0 for Kenvue over the recent three months.
Analyzing Volume & Open Interest
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Kenvue's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Kenvue's substantial trades, within a strike price spectrum from $19.0 to $23.0 over the preceding 30 days.
Kenvue Option Volume And Open Interest Over Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| KVUE | CALL | TRADE | BULLISH | 02/16/24 | $21.00 | $540.0K | 96.5K | 5.0K |
| KVUE | CALL | TRADE | BEARISH | 02/16/24 | $21.00 | $162.0K | 96.5K | 6.6K |
| KVUE | PUT | SWEEP | BEARISH | 01/19/24 | $20.00 | $66.5K | 5.0K | 1.2K |
| KVUE | CALL | SWEEP | BEARISH | 02/16/24 | $20.00 | $58.5K | 35.2K | 457 |
| KVUE | PUT | SWEEP | BEARISH | 01/19/24 | $20.00 | $48.0K | 5.0K | 501 |
About Kenvue
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Following our analysis of the options activities associated with Kenvue, we pivot to a closer look at the company's own performance.
Kenvue's Current Market Status
- Trading volume stands at 15,504,279, with KVUE's price down by -0.2%, positioned at $20.21.
- RSI indicators show the stock to be may be overbought.
- Earnings announcement expected in 73 days.
What The Experts Say On Kenvue
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $20.0.
- Reflecting concerns, an analyst from Piper Sandler lowers its rating to Neutral with a new price target of $20.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Kenvue, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
